Rudi Schmidt currently serves as CEO at !mmunetrue, a company that analyzes immunological patterns across diseases and treatments as humans respond systemically to environment, diseases, and treatments. Immunological real-world data have many use cases when curated, analyzed and provided by using artificial intelligence.

Before that, Rudi spent 15 years at Asklepios Hospitals, the 2nd largest hospital chain in Europe, the last 7 years as EVP Precision Medicine, and as CEO of several Asklepios affiliates, including a metagenome company and a provider of RWD and R&D.